• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

目前对派杰氏病的治疗和管理。

Current Management and Treatment of Extramammary Paget's Disease.

机构信息

Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.

出版信息

Curr Treat Options Oncol. 2022 Jun;23(6):818-830. doi: 10.1007/s11864-021-00923-3. Epub 2022 Apr 4.

DOI:10.1007/s11864-021-00923-3
PMID:35377101
Abstract

Extramammary Paget's disease (EMPD) is a rare neoplastic disease affecting areas rich in apocrine glands in the elderly. EMPD clinically resembles a benign inflammatory skin disease, and ill-defined tumor borders can lead to misdiagnosis and incomplete excision. Several prognostic factors have been reported, including nodule formation, tumor thickness, tumor invasion, lymphovascular invasion, and a perianal location, which are characteristic of primary tumors. EMPD typically presents as an in situ tumor spreading horizontally within the epidermis and then invading into the dermis as it transitions to a vertical growth phase. For this reason, tumor thickness, rather than tumor size, is correlated with patient prognosis. The best treatment for resectable EMPD is complete surgical removal of the tumor. EMPD sometimes has unclear tumor borders, and it can unexpectedly spread beyond its clinical boundaries. Surgical resection in such cases is often associated with tumor-positive margins, which can result in recurrence. However, surgical excision with wide margins may deteriorate patients' organ functions and quality of life. Mohs micrographic surgery may be ideal for controlling the surgical margins and minimizing the sacrifice of normal tissue, but this technique is not always feasible because of constraints associated with the medical environment. No standard treatment for unresectable or metastatic EMPD has been established. Although conventional chemotherapy has been used as the first-line treatment, it frequently causes adverse events, and consequently, targeted therapy will become more valuable in the near future.

摘要

乳房外帕哲病(EMPD)是一种罕见的肿瘤性疾病,好发于老年人富含大汗腺的部位。EMPD 临床上类似于良性炎症性皮肤病,且肿瘤边界模糊可导致误诊和不完全切除。已有多种预后因素被报道,包括结节形成、肿瘤厚度、肿瘤浸润、脉管浸润和肛周位置,这些都是原发性肿瘤的特征。EMPD 通常表现为原位肿瘤在表皮内水平扩散,然后在向垂直生长阶段过渡时侵入真皮。因此,肿瘤厚度而非肿瘤大小与患者预后相关。可切除 EMPD 的最佳治疗方法是完全切除肿瘤。EMPD 有时肿瘤边界不清晰,可能会出乎意料地超出其临床边界。在这种情况下,手术切除常伴有肿瘤阳性切缘,从而导致复发。然而,广泛切除边缘的手术可能会恶化患者的器官功能和生活质量。Mohs 显微外科手术可能是控制手术边缘和最小化正常组织牺牲的理想选择,但由于医疗环境的限制,该技术并非总是可行。对于不可切除或转移性 EMPD 尚无标准治疗方法。虽然常规化疗已被用作一线治疗,但它经常引起不良反应,因此,在不久的将来,靶向治疗将变得更加有价值。

相似文献

1
Current Management and Treatment of Extramammary Paget's Disease.目前对派杰氏病的治疗和管理。
Curr Treat Options Oncol. 2022 Jun;23(6):818-830. doi: 10.1007/s11864-021-00923-3. Epub 2022 Apr 4.
2
Extramammary Paget's Disease of genitourinary origin.泌尿生殖系统起源的乳腺外佩吉特病。
Curr Opin Urol. 2022 Mar 1;32(2):211-215. doi: 10.1097/MOU.0000000000000948.
3
A matter of margins: Surgical and pathologic risk factors for recurrence in extramammary Paget's disease.边缘问题:乳房外派杰特病复发的手术和病理危险因素。
Gynecol Oncol. 2017 Nov;147(2):358-363. doi: 10.1016/j.ygyno.2017.09.008. Epub 2017 Sep 19.
4
Prognostic Factors of Extramammary Paget's Disease: A Retrospective Study at a Medical Center in Taiwan.台湾一家医学中心的回顾性研究:外阴派杰氏病的预后因素。
In Vivo. 2023 Nov-Dec;37(6):2786-2791. doi: 10.21873/invivo.13390.
5
Therapeutic outcomes and survival analysis of Extramammary Paget's disease: A multicentre retrospective study of 249 patients.乳房外佩吉特病的治疗结果与生存分析:一项对249例患者的多中心回顾性研究。
J Am Acad Dermatol. 2024 Jan;90(1):66-73. doi: 10.1016/j.jaad.2023.08.088. Epub 2023 Sep 12.
6
Extramammary Paget's Disease: A Review of the Literature Part II: Treatment and Prognosis.乳房外 Paget 病:文献回顾 第二部分:治疗和预后。
Dermatol Surg. 2020 Mar;46(3):305-311. doi: 10.1097/DSS.0000000000002240.
7
Surgical treatment of extramammary Paget's disease. A report of six cases and a reexamination of Mohs micrographic surgery compared with conventional surgical excision.乳腺外佩吉特病的外科治疗。6例报告及对莫氏显微外科手术与传统手术切除的再审视。
Cancer. 1991 Feb 15;67(4):933-8. doi: 10.1002/1097-0142(19910215)67:4<933::aid-cncr2820670413>3.0.co;2-3.
8
Extramammary Paget's disease: a novel approach to treatment using a modification of peripheral Mohs micrographic surgery.乳房外佩吉特病:一种采用改良外周莫氏显微外科手术的新型治疗方法。
Ann Plast Surg. 2012 Jun;68(6):616-20. doi: 10.1097/SAP.0b013e31821b6c7b.
9
Prediction of surgical margin width using Mohs micrographic surgery for extramammary Paget's disease based on clinicopathological parameters: classification tree analysis of 150 cases.基于临床病理参数的 Mohs 显微外科治疗乳房外 Paget 病的手术切缘宽度预测:150 例分类树分析。
Eur J Dermatol. 2022 Feb 1;32(1):107-112. doi: 10.1684/ejd.2022.4204.
10
The treatment of anogenital extramammary Paget's disease as part of a multidisciplinary approach: The use of Mohs surgery moat method with CK7.肛门生殖器外佩吉特病的多学科治疗方法:Mohs 手术堤坝法联合 CK7 的应用。
Int J Dermatol. 2022 Feb;61(2):238-245. doi: 10.1111/ijd.15847. Epub 2021 Aug 26.

引用本文的文献

1
Perianal Paget's disease: an isolated extramammary manifestation of Paget's.肛周佩吉特病:佩吉特病的一种孤立性乳腺外表现。
BMJ Case Rep. 2025 Jul 1;18(7):e264532. doi: 10.1136/bcr-2024-264532.
2
A multicenter study on TROP2 as a potential targeted therapy for extramammary Paget disease in Japan.一项关于TROP2作为日本乳腺外佩吉特病潜在靶向治疗的多中心研究。
Sci Rep. 2025 Jan 2;15(1):409. doi: 10.1038/s41598-024-84566-y.
3
The clinical and pathological significance of tertiary lymphoid structure in extramammary Paget's disease.

本文引用的文献

1
Mucosal Invasion, but Not Incomplete Excision, Has Negative Impact on Long-Term Survival in Patients With Extramammary Paget's Disease.黏膜侵犯而非切除不完全,对乳房外佩吉特病患者的长期生存有负面影响。
Front Oncol. 2021 Apr 15;11:642919. doi: 10.3389/fonc.2021.642919. eCollection 2021.
2
The Outcome of Chemotherapy for Metastatic Extramammary Paget's Disease.转移性乳腺外佩吉特病的化疗结果
J Clin Med. 2021 Feb 12;10(4):739. doi: 10.3390/jcm10040739.
3
Unbiased Detection of Driver Mutations in Extramammary Paget Disease.非乳腺外帕哲病中驱动基因突变的无偏检测。
乳腺外佩吉特病中三级淋巴结构的临床和病理意义。
Front Immunol. 2024 Nov 15;15:1435629. doi: 10.3389/fimmu.2024.1435629. eCollection 2024.
4
Immunotherapy may be more appropriate for ERBB2 low-expressing extramammary paget's disease patients: a prognosis analysis and exploration of targeted therapy and immunotherapy of extramammary paget's disease patients.免疫疗法可能更适合ERBB2低表达的乳腺外佩吉特病患者:乳腺外佩吉特病患者的预后分析及靶向治疗与免疫疗法探索
Cancer Immunol Immunother. 2024 Oct 3;73(12):252. doi: 10.1007/s00262-024-03846-8.
5
FOXM1: a new therapeutic target of extramammary Paget disease.叉头框蛋白M1:一种乳腺外佩吉特病的新治疗靶点。
Sci Rep. 2024 Feb 19;14(1):4048. doi: 10.1038/s41598-024-54773-8.
6
Applications of photodynamic therapy in extramammary Paget's disease.光动力疗法在外阴佩吉特病中的应用。
Am J Cancer Res. 2023 Oct 15;13(10):4492-4507. eCollection 2023.
7
Identification of Predictive Factors for Post-operative Recurrence and Clinical Outcomes of Primary Vulvar Extramammary Paget Disease.原发性外阴 Paget 病术后复发的预测因素及临床结局的识别。
In Vivo. 2023 Nov-Dec;37(6):2618-2627. doi: 10.21873/invivo.13369.
8
KS-EMPD-1: a novel cell line of primary extramammary Paget's disease.KS-EMPD-1:一种原发性外阴 Paget 病的新型细胞系。
Hum Cell. 2023 Sep;36(5):1813-1829. doi: 10.1007/s13577-023-00951-1. Epub 2023 Jul 11.
Clin Cancer Res. 2021 Mar 15;27(6):1756-1765. doi: 10.1158/1078-0432.CCR-20-3205. Epub 2020 Dec 15.
4
Outcomes of lymph node dissection in the treatment of extramammary Paget's disease: A single-institution study.淋巴结清扫术治疗乳腺外派杰病的疗效:单中心研究。
J Dermatol. 2020 May;47(5):512-517. doi: 10.1111/1346-8138.15285. Epub 2020 Mar 10.
5
Weekly docetaxel monotherapy for metastatic extramammary Paget's disease: Retrospective single-institute analysis.多西他赛单药每周方案治疗转移性乳腺外佩吉特病:单机构回顾性分析
J Dermatol. 2020 Apr;47(4):418-422. doi: 10.1111/1346-8138.15255. Epub 2020 Feb 5.
6
Extramammary Paget disease of the vulva: Management and prognosis.外阴派杰病:处理与预后。
Gynecol Oncol. 2020 Apr;157(1):146-150. doi: 10.1016/j.ygyno.2019.11.009. Epub 2019 Nov 25.
7
Extramammary Paget's Disease: A Review of the Literature Part II: Treatment and Prognosis.乳房外 Paget 病:文献回顾 第二部分:治疗和预后。
Dermatol Surg. 2020 Mar;46(3):305-311. doi: 10.1097/DSS.0000000000002240.
8
Extramammary Paget Disease: A Review of the Literature-Part I: History, Epidemiology, Pathogenesis, Presentation, Histopathology, and Diagnostic Work-up.乳房外帕哲病:文献回顾——第一部分:历史、流行病学、发病机制、临床表现、组织病理学和诊断方法。
Dermatol Surg. 2020 Feb;46(2):151-158. doi: 10.1097/DSS.0000000000002064.
9
Single-agent taxane is useful in palliative chemotherapy for advanced extramammary Paget disease: a case series.单药紫杉烷用于晚期乳腺外佩吉特病的姑息化疗:病例系列
Br J Dermatol. 2019 Oct;181(4):831-832. doi: 10.1111/bjd.17922. Epub 2019 Jul 15.
10
Whole-Exome Sequencing Reveals Frequent Mutations in Chromatin Remodeling Genes in Mammary and Extramammary Paget's Diseases.全外显子组测序揭示了乳腺和乳腺外Pagets 病中染色质重塑基因的频繁突变。
J Invest Dermatol. 2019 Apr;139(4):789-795. doi: 10.1016/j.jid.2018.08.030. Epub 2018 Oct 25.